Neuroscience 2013

Nov 09 - 13 2013

San Diego, California

Neuroscience 2013, the Society for Neuroscience’s (SfN) Annual Meeting, is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies and advance careers. 

CNS Discoveries Start Here

Finding the right partner for your drug discovery research shouldn’t be such a challenge.

Charles River takes the guesswork out of CNS research, delivering world-class services that span the drug development continuum.

We’ll be at booth #2419 at the Society for Neuroscience 43rd Annual Meeting to share our expertise and to provide information about this year’s scientific poster presentations, which cover the latest discovery research targeting Huntington’s, Alzheimer’s, Parkinson’s and neurodegeneration.

In addition to exhibiting, Charles River will also be presenting the following posters:
 
Saturday, November 9, 2013

  • 2:00 pm – 3:00 pm, Validation of Preclinical Disease Models for Schizophrenia
  • 4:00 pm – 5:00 pm, Stabilized Neuropeptides in the SOD1 Mouse Model of ALS

Sunday, November 10, 2013

  • 8:00 am – 9:00 am, Nuclear Imaging Characterization of G93A-SOD1 Mouse Model of Amyotrophic Lateral Sclerosis
  • 9:00 am – 10:00 am, Evaluation of Fine Motor Skill Impairment in the G93A-SOD1 Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
  • 9:00 am – 10:00 am, Targeted Over-expression with AAV-Mediated Human α-synuclein in a Rat Model of Parkinson’s Disease - Validation of Novel Fine Motor Functional Effects, As Well As Neurochemical and Neuropathological Changes Over Time
  • 10:00 am  - 11:00 am, Longitudinal Characterization of CVN Mouse for Alzheimer's Disease Using Behavioral, Imaging and Biomarker End-Points

Monday, November 11, 2013

  • 10:00 am – 11:00 am, Evaluation of Fine Motor Skill Impairment of R6/2 and zQ175 Knock-in mice and BAC Rats of Huntington's Disease
  • 11:00 am – 12:00 pm, Longitudinal Anatomical, Metabolic and Functional Changes by MRI/MRS and PET and SPECT in zQ175 Knock-in Mouse Model of Huntington's Disease
  • 4:00 pm – 5:00 pm, Differential Distribution of G-CSF Transduced Human Mesenchymal Stem Cells in Stroke
  • 4:00 pm – 5:00 pm, The Dichotomy and Polar Opposites Observed Between the Experimental Acute Encephalitis Murine Model and Human Secondary Progressive Multiple Sclerosis; Insight into Their Respective Pathogeneses Via a Neuropeptide Mediated Mechanism

Tuesday, November 12, 2013

  • 9:00 am – 10:00 am, Impaired Thermoregulatory Capacity in R6/2 and xQ175 Mouse Models of Huntington's Disease During Cold Challenge
  • 10:00 am – 11:00 am, Immunohistochemical Characterization of R6/2 Transgenic and zQ175 Knock-in Mouse Models of Huntington's Disease
  • 4:00 pm – 5:00 pm, Dysferlin Deficient Mice Show Muscle Dystrophy by MRI and Deficiency in Energy Metabolism

Wednsday, November 13, 2013

  • 9:00 am – 10:00 am, Hyperimmune Caprine Serum - A Multi-focal Therapeutic Strategy in Early and Late-stage Alzheimer's Disease

For more information on Charles River's participation, click here or contact us at events@crl.com. For more information about the show in general, please visit the Society for Neuroscience website.